Vestal Point Capital
TEVA icon

Vestal Point Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Vestal Point Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200,000
Closed -$2.09M – 74
2023
Q4 		$2.09M Buy
+200,000
New +$1.87M 0.22% 37

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vestal Point Capital's TEVA Position: Q1 2024 in Review

Vestal Point Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2024, closing a stake of 200,000 shares — an estimated $2.09M sold.

Vestal Point Capital first reported a position in TEVA in Q4 2023 and held it in 1 quarter. The position peaked at $2.09M in Q4 2023. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Vestal Point Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2024 after selling out during the quarter.
  • Vestal Point Capital sold 200,000 Teva Pharmaceutical Industries Limited shares in Q1 2024, an estimated $2.09M.
  • Vestal Point Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and held it in 1 quarter.
  • Vestal Point Capital's Teva Pharmaceutical Industries Limited position peaked at $2.09M in Q4 2023.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2024.

Based on Vestal Point Capital's 13F filing for Q1 2024, filed 14 May 2024.